Lawrence pointed out that a five-year course of treatment for MS with Tysabri, made by Biogen Idec and Elan Pharmaceuticals, costs about $140,000, and he charges $3,050.
"If you were in business, would you replace a drug that earned you $140,000 over five years with a parasite that might earn you $4,000 that was more effective? All the drugs that are on the market -- Methotrexate, Tysabri, Humira -- all these drugs would suddenly be worthless," he says. "It's not going to happen, is it?"
He said that the U.S. Food and Drug Administration is putting stumbling blocks that is delaying his chance to give people the opportunity for his treatment in the United States. He offers the treatment in Great Britain and in Mexico.
The way it works is that Lawrence puts about three dozen hookworms on a bandage and they burrow into your arm and then into the bloodstream. They eventually make their way to the lungs, where they are coughed up and wind up in the small intestine.
Lawrence had treated more than 180 people, as well as himself